Incyte Corp (NAS:INCY)
$ 57.05 -0.55 (-0.95%) Market Cap: 12.83 Bil Enterprise Value: 9.14 Bil PE Ratio: 17.29 PB Ratio: 2.38 GF Score: 88/100

Incyte Corp at Evercore ISI HealthCONx Conference Transcript

Dec 01, 2020 / 03:30PM GMT
Release Date Price: $85.42 (+1.04%)
Maneka Mirchandaney
Evercore ISI Institutional Equities, Research Division - Analyst

Great. Good morning, everyone. This is Maneka Mirchandaney from the Evercore ISI biotech team. I'm really pleased to be here with Incyte. We've got Hervé, Christiana, Mike and Christine from the team. Thank you all for being here.

Questions & Answers

Maneka Mirchandaney
Evercore ISI Institutional Equities, Research Division - Analyst

And maybe to start, can you just give us a quick sense for where Incyte is now? And what the key areas of focus for the company are going to be over the next couple of years?

Herve Hoppenot
Incyte Corporation - Chairman, President & CEO

Okay. Well, good morning. Happy to be here to speak about that. I mean the way we look at -- I mean, it has been a fairly busy year. It was a little bit of a paradox because we were dealing with the COVID situation. And then at the same time, we had like 3 new approvals during the year. We have been in a fairly busy phase of the -- in the life of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot